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Understanding the ontogeny of the human immune system is a
prerequisite to developing efficient and safe interventions aimed
at providing long-term protection against infectious pathogens
or inflammatory disorders originating early in life. The immune
system of the fetus and the newborn infant had long been con-
sidered as “immature.” This insight is based on the observation
that infectious diseases are often more severe or more pro-
longed in early life. However, studies performed in the 80s have
shown that cells involved in innate immune responses develop
as early as the fourth week of gestation in humans and that
mature fetal T and B lymphocytes can be detected by the end
of the first trimester of gestation already. More recent evidence
indicates that fetal precursors are at the origin of adult tissue-
resident macrophages. In addition, studies of immune responses
to alloantigens and pathogens in utero demonstrated that effector
and regulatory responses are operational during human fetal life,
further indicating that the immune system is not fundamentally
immature in early life, but simply differs from immune responses
observed in later life. Studies are now needed to determine the
signals involved in the regulation of the functional programing
of immune cells in early life and to define how these signals
could be targeted to protect against infectious diseases as well as
chronic inflammatory disorders. The objective of the Research
Topic is to provide an overview of the current state of knowledge
of the ontogeny of the immune system and of the pathogenesis of
important infectious and inflammatory diseases in early life. Four
themes emerged from the excellent contributions that have been
assembled here.
FETAL ORIGIN OF INNATE CELLS
Recent studies indicate that a number of innate cell subsets
derive from fetal progenitors and self-maintain throughout life.
Vermijlen and Prinz reviewed the development of innate lym-
phocytes (1). The innate features of these lymphocytes include
the recognition of molecular patterns, their rapid responses, and
the fact that they do not undergo clonal expansion. Innate lym-
phocytes can express rearranged γδ or αβ (iNKT and MAIT
cells) T cell receptors (TCR) or express no TCR (ILCs). The
authors propose that some subsets are “more innate than oth-
ers” because they develop in the fetal thymus and cannot be
regenerated in the adult thymus. Whereas the signals required for
the development of most subsets of innate lymphocytes remain
unknown, cells expressing semi-invariant TCR develop under
the influence of small metabolites associated with monomor-
phic presenting elements. The ontogeny of myeloid cells was
reviewed by De Kleer et al. (2). Mouse studies have demonstrated
that adult tissue-resident macrophages derive either from fetal
yolk sac macrophages or from fetal liver-derived monocytes. In
contrast, bone marrow precursors replenish dendritic cell sub-
sets as well as inflammatory macrophages and myeloid-derived
suppressor cells (MDSC) throughout life. Myeloid cells are dif-
ferently programed in early life as compared to adult life and
express different levels of effector molecules involved in tissue
growth and remodeling, inflammation, and induction of adap-
tive immune responses. As reviewed by Debock and Flamand, a
similar development influences the functional programing of T
lymphocytes, where the balance between regulatory and effector
responses changes between fetal life and adult life (3). Krow-
Lucal and McCune discuss the fact that many of the functions
of lymphoid and myeloid cells derived from fetal hematopoietic
stem cells (HSC) are involved in barrier integrity and induction
of tolerance and propose that immune maturation may proceed
in a layered fashion with a fetal system predominating in utero
and an adult system predominating later in life (4). In addi-
tion to differences in the origin of HSCs, several regulatory sig-
nals contribute to the maintenance of tolerance to non-inherited
maternal antigens and to commensal bacteria in fetal and early
post-natal life.
IMMUNE REGULATION IN EARLY LIFE
As observed at the maternal side of the materno-fetal interface, a
number of potentially redundant regulatory mechanisms are oper-
ational in the fetus and the newborn infant that promote immune
homeostasis in utero and in the early post-natal life. These mech-
anisms involve cellular components and soluble mediators. As
reviewed by Gantt et al., among the cellular components, MDSCs
are present at high frequencies in early human life and could there-
fore play an important role in immune homeostasis (5). Pettengill
et al. reviewed current knowledge of soluble mediators regulating
T cell responses in early life (6). The evidence indicate that several
components promoting pro-inflammatory T cell responses, such
as the complement system, are produced at lower levels in early
life whereas regulatory mediators, such as adenosine, promoting
regulatory T cell responses are produced at higher levels than in
adult life. An immune environment programed toward regula-
tion may have an important impact on the susceptibility of the
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fetus and the young infant to infectious pathogens and on their
responses to vaccines. Although the evidence for this notion largely
remains to be provided in humans, mouse studies of the ontogeny
of intestinal innate immune responses indicate important changes
in the expression of innate receptors and downstream signaling in
epithelial cells. As reviewed by Hornef and Fulde, these changes
probably play a critical role in the establishment of host–microbial
homeostasis but may also play contribute to the susceptibility to
enteric pathogens (7).
IMMUNITY TO PATHOGENS IN EARLY LIFE
Understanding the pathogenesis of infectious diseases in early life
is required for the development of effective interventions pro-
tecting young children but also sheds light on the ontogeny of
immune responses in vivo in humans. A number of intracellular
pathogens cause more severe disease or replicate at higher lev-
els in the fetus and young child as compared to the adult. This
reduced pathogen control could be related to a defect in the devel-
opment of cell-mediated immune responses. Muenchhoff et al.
review the evidence suggesting that the increased viral replication
and rapid disease progression associated with pediatric HIV infec-
tion may involve reduced Th1 responses and increased regulatory
T cell responses (8). In addition, they suggest that the relatively
low frequencies of memory CD4 T cells present during the first
months of life may reduce the HIV reservoir and may thereby
provide opportunities for curative interventions. An unbalanced
T cell response may also play an important role in the increased
susceptibility of young children to RSV infection. As reviewed by
Lambert et al., dysregulated Th2 and Th17 responses may limit
viral control and promote inflammatory responses in the airways
of RSV-infected children (9). Huygens et al. reviewed the studies of
congenital CMV infection indicating that high frequencies of anti-
viral γδ and αβ T cells can be induced early during fetal life (10).
Recent studies further suggest that functional exhaustion may be
an important factor regulating effector T cell responses in early life.
On the other hand, Bertoletti and Hong propose that the different
clinical manifestations of HBV infection in young infants and in
adults are related to differences in the host ability to trigger inflam-
matory responses rather than to immunological tolerance to the
virus (11). These reviews provide a framework to further delineate
protection from disease due to intracellular pathogens in early life.
If common principles directing immune responses in early life are
emerging, the immunological determinants of the clinical expres-
sion of infections probably involve pathogen-specific factors. This
notion is illustrated by the studies of GBS infection. As reviewed
by Landwehr-Kenzel and Henneke, the innate immune mecha-
nisms involved in the control of the GBS niche at the mucosal
level may also play a central role in the immunopathology asso-
ciated with invasive infections and subtle changes in this balance
may be critical to the susceptibility of newborn infants to GBS
sepsis (12).
GENES AND ENVIRONMENT
As discussed by Newport, most immune responses show wide-
ranging inter-individual variation within a population, indicating
a multifactorial etiology where both genes and environmental fac-
tors interact (13). Vaccine studies provided evidence that genetic
factors are important determinants of immune responses in early
life. However, our understanding of the genetic factors involved
in the control of immune responses to vaccines and infectious
pathogens in infants remains limited. At the same time, a large
number of environmental factors can modulate immunity dur-
ing fetal and early post-natal life. As reviewed by MacGillivray and
Kollmann, these factors include nutrients, chemicals, commensals,
and infectious pathogens (14). The consequences of the exposure
to these environmental factors can be short-term or have life-
long implications. As the environmental factors profoundly evolve
between fetal life and adult life, the immune system is likely to be
programed to have the capacity to adapt to these changes. One
striking example of an evolving environment is the establishment
of the microbiome. Microbial colonization begins at birth and the
content of the microbiome continues to evolve during the first
years of life. These evolving microbial signals could play a central
role in the evolution of the functional programing of immune cells
during this period. As reviewed by Arrieta et al., imbalances of the
gut microbiome in early life are associated with the development of
several chronic inflammatory disorders, including inflammatory
bowel diseases and asthma (15). Asthma is a complex disease with
multiple factors acting in concert over long time periods. In their
review, Walker et al. characterized the complexity of the asthma
phenotype and propose that prospective birth cohorts recording
large datasets of clinical, physiological, biochemical, immunolog-
ical, and microbiological markers over time are required to gain
new insights into the pathogenesis of asthma (16). Although the
Research Topic does not include contributions on other chronic
inflammatory disorders that may originate in early life, it is likely
that similar approaches will be required to unravel their complex
pathogenesis. In addition to the financial and logistical challenges
of such studies, tools to support the complex data analysis and
statistical modeling will have to be developed. Another critical fac-
tor forming the immune environment of the fetus and the young
infant is composed by the maternal antibodies transferred through
the placenta and the breastmilk. As reviewed by Niewisk, mater-
nal antibodies not only protect against pathogens to which the
mother has been exposed but also decrease responses to many
vaccines through complex interactions with infant B cells (17). A
better understanding of the transfer of immunity from the mother
to the young child is likely to open new avenues for the prevention
of infectious diseases in early life through maternal and neonatal
immunization.
The rich series of manuscripts included in this Research Topic
only covers a fraction of the emerging knowledge about immune
ontogeny and its role in the promotion of health in early life. Yet,
it clearly indicates that this field of research is developing more
actively than ever and that fetal life and early infancy are increas-
ingly recognized as a critical period to shape the immune system
for life. This has similarly been recognized in the “1000 days” (i.e.,
from conception to age 2 years) campaign (18) and the WHO’s
Every Newborn Action Plan (19). Together with the manuscripts
in this Research Topic of Frontiers in Immunology, early life can be
seen not only as a window of vulnerability to infectious morbidity
and mortality but also as a window of opportunity to promote
immune-mediated health for life. As emphasized by Christopher
Wilson, translating emerging biological knowledge into new and
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effective interventions will require that immunologists leave their
silos and build bridges across a wide range of disciplines (20).
We thank all the authors of the manuscripts for their very generous
contributions to this project.
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